Roccatello et al. AAV with severe AKI. RTX+CYC+methylpred+no maintenance vs CYC+AZA maintenance. No difference in overall survival, 6-month therapeutic response rate, and 6-, and 12-month functional renal recovery. @RheumNow #ACR22 Abstr#1083 https://t.co/yv12bzwq6x https://t.co/YXUjpSzZ6I
Links:
Treatment of ANCA-associated Vasculitis with Extreme Impairment of Renal Functi…
https://acrabstracts.org/abstract/treatment-of-anca-associated-vasculitis-with-…
13-11-2022
